384
Participants
Start Date
January 31, 2012
Primary Completion Date
June 30, 2012
Study Completion Date
June 30, 2012
Palonosetron
palonosetron 0.075 mg intravenous injection over 10 seconds when nausea with NRS \>= 4, or developement of retching or vomiting more than one time within three hour after the end of surgery.
placebo control group
placebo intravenous injection over 10 seconds when nausea with NRS \>= 4, or developement of retching or vomiting more than one time within three hour after the end of surgery.
Samsung Medical Center, Seoul
Bungdang Seoul National University Hospital, Seoul
Kangpook Samsung Hospital, Seoul
Sangye Bahk Hospital, Inje School of Medicine, Seoul
Collaborators (1)
HK inno.N Corporation
INDUSTRY
Samsung Medical Center
OTHER